![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
February 19, 2025
This is the first randomized phase 3 study to evaluate autologous stem cell transplantation in patients with this rare and aggressive form of non-Hodgkin lymphoma
February 19, 2025
Seven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG
December 23, 2024
This phase 2 study will test a new treatment combination for patients with certain subtypes of relapsed or refractory B-cell lymphoma
December 23, 2024
Summaries of presentations at the 2024 San Antonio Breast Cancer Symposium as well as the 66th American Society of Hematology Annual Meeting and Exposition in San Diego
November 25, 2024
October 17, 2024
Summaries of recently published ECOG-ACRIN research results
September 17, 2024
Summaries of recently published ECOG-ACRIN research results
August 14, 2024
Summaries of recently published ECOG-ACRIN research results
July 3, 2024
Summaries of recently published ECOG-ACRIN research results
April 9, 2024
Summaries of recently published ECOG-ACRIN research results
March 7, 2024
Summaries of recently published ECOG-ACRIN research results
August 25, 2023
Summaries of recently published ECOG-ACRIN research results